Showing 4541-4550 of 5646 results for "".
- Over 20,000 Screened for Glaucoma in India and Nigeria Thanks to Joint Initiative, Keep Sighthttps://modernod.com/news/over-20000-screened-for-glaucoma-in-india-and-nigeria-thanks-to-joint-initiative-keep-sight/2478954/Allergan, Sightsavers, and the International Agency for the Prevention of Blindness (IAPB) launched the Keep Sight 2020 video report. The report details the results from the first year of their joint initiative, funded by Allergan, which aims to prevent glaucoma-related vision loss in un
- Allergan Launches Glaucoma in Perspective Apphttps://modernod.com/news/allergan-launches-glaucoma-in-perspective-app/2478950/Allergan has announced the launch of Glaucoma in Perspective (GiP), an app designed to help patients understand the impact of glaucoma, improve quality of life, and reduce disease progression by promoting treatment adherence. The GiP app has been produced and funded by Allergan, with consu
- CorNeat Vision Partners with LiveU and Alcon for Remote Surgeon Virtual Presencehttps://modernod.com/news/corneat-vision-partners-with-liveu-and-alcon-for-remote-surgeon-virtual-presence/2478949/CorNeat Vision and LiveU, a provider of live video streaming and remote production solutions, announced that they have partnered and implemented an on-demand Remote Surgeon Virtual Presence (RSVP) solution. The companies cooperated with Alcon to leverage its NGENUITY 3D Visualization Syste
- UK, Four Other Countries to Fast-Track Vaccines for SARS-CoV-2 Variantshttps://modernod.com/news/uk-four-other-countries-to-fast-track-vaccines-for-sars-cov-2-variants/2478939/A group of regulatory authorities from the UK, Australia, Canada, Singapore and Switzerland issued new rules Thursday aimed at speeding up the development of modified COVID-19 vaccines against emerging SAR-CoV-2 strains. The guidance, developed by the UK’s Medicines and Healthcare products
- Retina Consultants of America Continues Growth With Partnership in Kansas and Missourihttps://modernod.com/news/retina-consultants-of-america-continues-growth-with-partnership-in-kansas-and-missouri/2478935/Retina Consultants of America (RCA) announced it has added Retina Associates, P.A. of Kansas City, based in Kansas and Missouri, to its group of practices. Retina Associates, P.A. serves the greater Kansas City, Topeka, Sedalia, and surrounding areas. Terms of the deal were no
- Eyenovia Announces FDA Acceptance of Filing of NDA for MydCombihttps://modernod.com/news/eyenovia-announces-fda-acceptance-of-the-mydcombi-nda/2478929/Eyenovia announced that the FDA has accepted the company’s new drug application (NDA) for MydCombi, a unique fixed combination mydriatic (pupil dilation) agent. If approved, MydCombi would be the first microdosed ocular therapeutic applied with a high precision smart delivery system, the Optejet.
- Trial to Compare Efficacy and Safety Outcomes of Ab-Interno Canaloplasty for Glaucomahttps://modernod.com/news/trial-to-compare-efficacy-and-safety-outcomes-of-ab-interno-canaloplasty-for-glaucoma/2478931/Nova Eye Medical has reported that eight surgery centers across the US have commenced a prospective, multicenter, randomized trial to assess the efficacy and safety outcomes of ab-interno canalop
- Clearside Biomedical Completes Patient Dosing in First Cohort of Phase 1/2a Clinical Trial of CLS-AX for the Treatment of Wet AMDhttps://modernod.com/news/clearside-biomedical-completes-patient-dosing-in-first-cohort-of-phase-1-2a-clinical-trial-of-cls-ax-for-the-treatment-of-wet-amd/2478927/Clearside Biomedical announced completion of dosing in the first cohort of OASIS, its ongoing phase 1/2a clinical trial of CLS-AX (axitinib injectable suspension) in patients with wet age-related macular degeneration (AMD). OASIS is a US-based, multicenter,
- SalioGen Therapeutics Announces Closing of $20 Million Series A Financing to Advance Gene Therapieshttps://modernod.com/news/saliogen-therapeutics-announces-closing-of-20-million-series-a-financing-to-advance-gene-therapies/2478925/SalioGen Therapeutics announced that it has closed a $20 million Series A financing to support the preclinical validation of the company’s proprietary Exact DNA Integration Technology (EDIT) platform for the development of durable, safe and affordable in vivo gene the
- Study: Smartphones Could Help to Prevent Glaucoma Blindnesshttps://modernod.com/news/study-smartphones-could-help-to-prevent-glaucoma-blindness/2478918/Smartphones could be used to scan people’s eyes for early-warning signs of glaucoma, helping to prevent severe ocular diseases and blindness, a new study reveals. Soundwaves used as a mobile measurement method would detect increasing values of IOP, prompting early diagnosis and treatment.</